Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.100
+0.279 (33.90%)
At close: Nov 20, 2024, 4:00 PM
0.971
-0.129 (-11.75%)
Pre-market: Nov 21, 2024, 5:49 AM EST
Coherus BioSciences Employees
Coherus BioSciences had 306 employees as of December 31, 2023. The number of employees decreased by 53 or -14.76% compared to the previous year.
Employees
306
Change (1Y)
-53
Growth (1Y)
-14.76%
Revenue / Employee
$994,575
Profits / Employee
-$1,471
Market Cap
126.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Protalix BioTherapeutics | 208 |
Zomedica | 144 |
Adverum Biotechnologies | 121 |
TriSalus Life Sciences | 112 |
Compugen | 68 |
Milestone Pharmaceuticals | 47 |
Fennec Pharmaceuticals | 29 |
Zentek | 24 |
CHRS News
- 14 days ago - Coherus BioSciences, Inc. (CHRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 21 days ago - Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 3 months ago - Evaluating Coherus BioSciences: Udenyca's Success And Loqtorzi's Prospects - Seeking Alpha
- 3 months ago - Coherus BioSciences, Inc. (CHRS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024 - GlobeNewsWire
- 5 months ago - Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction - GlobeNewsWire
- 6 months ago - Coherus BioSciences: CHS-114 Comes Into View At ASCO, Drug Launches Underway - Seeking Alpha